CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS LIMITED

遠 大 醫 藥 健 康ġ控 股 有 限 公 司*

(Incorporated in Bermuda with limited liability)

(Stock Code: 00512)

Proxy Form

For the annual general meeting to be held on 1 June 2021 or any adjournment thereof

I/We (Note 1)

of

being the registered holder(s) of (Note 2)ordinary shares of HK$0.01 each

in the capital of China Grand Pharmaceutical and Healthcare Holdings Limited (the ''Company''), HEREBY APPOINT the chairman of

the Meeting or (Note 3)

or

of

failing him/her

of

as my/our proxy to attend and vote for me/us and on my/our behalf at the annual general meeting of the Company (the ''Meeting'') to be

held at Unit 3302, The Centre, 99 Queen's Road Central, Hong Kong on 1 June 2021 at 11:00 a.m. and at any adjournment thereof in respect of the resolutions as indicated below (Note 4) or, if no such indication is given, as my/our proxy thinks fit.

ORDINARY RESOLUTIONS (Note 5)

FOR

AGAINST

  1. To adopt the audited financial statements together with the report of the directors and the report of the auditors for the year ended 31 December 2020.
  2. To declare a final dividend of HK$0.11 per share for the year ended 31 December 2020.

3.

(a)

To appoint Dr. Tang Wei Kun as an executive director.

(b)

To appoint Dr. Shi Lin as an executive director.

(c)

To re-elect Mr. Hu Yebi as an independent non-executive director.

(d)

To authorise the board of directors to fix the directors' remuneration.

  1. To re-appoint HLB Hodgson Impey Cheng Limited as auditors to hold office until the conclusion of the next annual general meeting of the Company and to authorise the board of directors to fix their remuneration.
  2. To adopt ordinary resolution no. 5 as set out in the Notice (to give a general mandate to the directors to issue shares in the Company).
  3. To adopt ordinary resolution no. 6 as set out in the Notice (to give a general mandate to the directors to repurchase shares in the Company).
  4. To adopt ordinary resolution no. 7 as set out in the Notice (to extend the general mandate to the directors to issue shares in the Company).

Dated this

day of

2021

Signature:

Notes:

  1. Full name(s) and address(es) to be inserted in BLOCK CAPITALS.
  2. Please insert the number of shares registered in your name(s). If no number is inserted, this proxy form will be deemed to relate to all the shares of the Company registered in your name(s).
  3. If any proxy other than the chairman of the Meeting is preferred, strike out ''the chairman of the Meeting or'' and insert the name and address of the proxy desired in the space provided. The proxy need not be a shareholder of the Company but must attend the Meeting in person to represent you.
  4. If you wish to vote for a resolution, place a tick ''P'' in the column marked ''For''. If you wish to vote against a resolution, place a tick ''P'' in the column marked ''Against''. If no indication is given, the proxy will vote or abstain at his/her discretion.
  5. The full text of the resolutions is set out in the notice of the Meeting dated 29 April 2021.
  6. Corporations must execute this proxy form under common seal or under the hand of an attorney or a duly authorised officer. If a legal representative is appointed to attend the Meeting, such legal representative shall produce his/her own identity paper and a certified true copy of the resolution of the board of directors or other governing body of the corporation appointing the legal representative.
  7. To be valid, this proxy form, together with any power of attorney or other authority (if any) under which it is signed or a certified copy of such power of attorney, must be deposited at the Company's branch registrar in Hong Kong, Computershare Hong Kong Investor Services Limited at Shops 1712- 1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not less than 48 hours before the time appointed for holding the Meeting or adjournment thereof.
  8. Completion and delivery of this proxy form will not preclude you from attending and voting at the Meeting if you so wish.
  • For identification purpose only

Attachments

  • Original document
  • Permalink

Disclaimer

China Grand Pharmaceutical and Healthcare Holdings Ltd. published this content on 29 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 April 2021 23:08:06 UTC.